Century Therapeutics Inc (IPSC) earnings · $47.8M cap
These earnings events as JSON? API free 100/dayCentury Therapeutics Inc (IPSC) is a biotechnology company listed on US.
This IPSC earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported IPSC revenue for 2025-09-30 was $109.2M. Net income was $9.6M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. IPSC currently screens at market cap $47.8M.
When the next IPSC 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 0.0% from 2025-06-30 to 2025-09-30. An earnings headline that ignores that move is noise.
Not investment advice. Full IPSC research stays on the stock page; the tape stays on the quote page.
IPSC earnings FAQ
What are IPSC's latest revenue and net income?
Latest cached Century Therapeutics Inc (IPSC) revenue for Sep 30, 2025 was $109.2M. Net income was $9.6M. Statements: https://lician.com/financials/ipsc
What period does the latest IPSC earnings print cover?
The latest cached Century Therapeutics Inc (IPSC) earnings print covers Sep 30, 2025. The prior cached period on this page is Jun 30, 2025.
How did IPSC revenue change from the prior cached period?
Cached Century Therapeutics Inc (IPSC) revenue was unchanged from $109.2M (Jun 30, 2025) to $109.2M (Sep 30, 2025). Statements: https://lician.com/financials/ipsc
Where are IPSC earnings listed?
Cached earnings facts for Century Therapeutics Inc (IPSC) are listed at https://lician.com/earnings/ipsc. Statements: https://lician.com/financials/ipsc
Not investment advice.